Skip to content
URAC
  • Accreditations & Certifications
    • General Information
      • Accreditation Process
      • Accreditation Standards
      • Accreditation FAQs
      • Directory
    • Accreditation & Certification Programs
      • Pharmacy
      • Health Plan Programs
      • Digital/Telehealth
      • Mental Health/Substance Use Disorder Parity
      • Patient Care Management
      • Administrative Management
      • View All Accreditation & Certification Programs
  • Outcomes & Measures
    • About Measures
    • Measurement FAQs
    • Measurement Process and Reporting
    • Leaders in Performance Measurement
    • Performance Measurement Results
  • About URAC
    • History
    • Mission
    • Client Testimonials
    • Executive Team
    • Board of Directors
    • Partners
    • Committee/Council Membership
    • Careers
  • News
  • Events
    • Upcoming Events
    • On-Demand Events
  • Contact
    • Directory
    • Submit an Interpretations Inquiry
    • File a Grievance
  • URAC International
  • Contact
    • Submit an Interpretations Inquiry
    • File a Grievance
  • Client Information Hub
URAC
  • Accreditations & Certifications
    • General Information
      • Accreditation Process
      • Accreditation Standards
      • Accreditation FAQs
      • Directory
    • Accreditation & Certification Programs
      • Pharmacy
      • Health Plan Programs
      • Digital/Telehealth
      • Mental Health/Substance Use Disorder Parity
      • Patient Care Management
      • Administrative Management
      • View All Accreditation & Certification Programs
  • Outcomes & Measures
    • About Measures
    • Measurement FAQs
    • Measurement Process and Reporting
    • Leaders in Performance Measurement
    • Performance Measurement Results
  • About URAC
    • History
    • Mission
    • Client Testimonials
    • Executive Team
    • Board of Directors
    • Partners
    • Committee/Council Membership
    • Careers
  • News
  • Events
    • Upcoming Events
    • On-Demand Events
  • Contact
    • Directory
    • Submit an Interpretations Inquiry
    • File a Grievance
October 27, 2020

URAC and 80 Organizations Call on DEA to Create Registry for Telemedicine Treatment of Substance Abuse

Posted in Government Relations, Telehealth

On Oct. 26th, URAC joined 80 other organizations, led by the Alliance for Connected Care, is calling for the U.S. Drug Enforcement Administration (DEA) to implement a telemedicine special registration. This registration process would enable providers to safely prescribe controlled substances remotely.

The nation’s response to COVID-19 has demonstrated the value of increased access to telemedicine to enable all qualified providers, including Community Mental Health Centers and addiction treatment facilities, to prescribe Medication Assisted Treatment (MAT) to patients with Opioid Use Disorder (OUD).

The failure to have a registry to allow for providers of telemedicine services to prescribe is a failure of the bureaucracy. On October 24, 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act. This legislation required the Attorney General, in consultation with the Secretary of Health and Human Services (HHS), to announce regulations specifying the circumstances for a special registration for telemedicine.

It has been a full two years since adoption of the SUPPORT Act and no meaningful progress has been made to further the execution of this critical policy.

Since the outset of the COVID-19 epidemic, the DEA, in partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA), decided to allow remote prescribing of controlled substances using telemedicine without a prior in-person exam, regardless of the patient’s location. While this update is vital to ensuring patients continue to have access to the care they require, such an emergency action is only required because the DEA and other federal agencies have failed to execute the requirements of the SUPPORT Act.

Given the worsening opioid overdose crisis, URAC and 80 stakeholder organizations urge the DEA to move forward with the telemedicine special registration process required by federal law that will enable SAMHSA waivered clinicians, Community Mental Health Centers and addiction treatment facilities to prescribe MAT to patients with OUD via telemedicine technology.

By URAC Staff
Share this

Which URAC accreditations are right for your organization?

Take the Quiz

Recent Posts

  • ALOTEB Becomes URAC’s First Telehealth Customer in the UAE
  • URAC and The National Minority Quality Forum Explore Development of Health Equity Standards
  • URAC Launches Improved Health Plan Accreditation
  • URAC and Care Pharmacies Cooperative Announce Strategic Partnership
  • URAC and HOSP Announce Strategic Relationship

Topics

  • Administrative Management
  • ANET
  • Behavioral Health
  • Case Management
  • Client Interviews
  • Digital Health
  • Employment
  • Events
  • Gold Star Talks
  • Government Relations
  • Health Care
  • Health Management
  • Health Plan
  • Hospitals and Health Systems
  • Industry Event
  • Mental Health Parity
  • Opioid Stewardship
  • Other Topics
  • Outcomes and Measures
  • Patient Management
  • Pharmacy
  • Press Release
  • Remote Patient Management
  • Telehealth
  • URAC COVID Policy
  • URAC News

Ready to start your accreditation or certification journey?

Still have questions? We look forward to answering them and making you comfortable with the process.

Let's Talk

Let's Talk

  • By providing your contact information through this Request a Quote form, you agree to be contacted by a member of our Business Development team. You also agree to receive email communications from URAC about products and services relevant to your inquiry. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

urac logo

1220 L Street NW
Suite 900
Washington, DC 20005
202-216-9010

  • Accreditations & Certifications
    • General Information
      • Accreditation Process
      • Accreditation Standards
      • Accreditation FAQs
      • Directory
    • Accreditation & Certification Programs
      • Pharmacy
      • Health Plan Programs
      • Digital/Telehealth
      • Mental Health/Substance Use Disorder Parity
      • Patient Care Management
      • Administrative Management
      • View All Accreditation & Certification Programs
  • Outcomes & Measures
    • About Measures
    • Measurement FAQs
    • Measurement Process and Reporting
    • Leaders in Performance Measurement
    • Performance Measurement Results
  • About URAC
    • History
    • Mission
    • Client Testimonials
    • Executive Team
    • Board of Directors
    • Partners
    • Committee/Council Membership
    • Careers
  • News
  • Events
    • Upcoming Events
    • On-Demand Events
  • Contact
    • Directory
    • Submit an Interpretations Inquiry
    • File a Grievance
  • Code of Conduct
  • Terms of Use
  • Privacy Policy
  • Accessibility
  • Sitemap
  • Contact
  • File a Grievance
  • Submit an Interpretations Inquiry
Client Login

URAC 2020 Platinum Award

2021 MarCom
Platinum Award Winner

Website | Redesign
Writing | White Paper

© 2022 URAC. All Rights Reserved.

Website by Yoko Co

Scroll To Top